vs
Side-by-side financial comparison of BRT Apartments Corp. (BRT) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
BRT Apartments Corp. is the larger business by last-quarter revenue ($24.3M vs $13.2M, roughly 1.8× TriSalus Life Sciences, Inc.). BRT Apartments Corp. runs the higher net margin — -17.8% vs -73.9%, a 56.1% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 1.3%). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 1.9%).
BRT Apartments Corp is a publicly traded real estate investment trust that owns, operates, and develops multi-family residential properties primarily across high-growth markets in the United States. Its core portfolio consists of garden-style and mid-rise apartment communities, serving diverse renter groups while targeting long-term asset value appreciation and stable dividend returns for its shareholders.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
BRT vs TLSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.3M | $13.2M |
| Net Profit | $-4.3M | $-9.8M |
| Gross Margin | — | 86.7% |
| Operating Margin | -14.3% | -24.8% |
| Net Margin | -17.8% | -73.9% |
| Revenue YoY | 1.3% | 59.8% |
| Net Profit YoY | -108.7% | 3.5% |
| EPS (diluted) | $-0.23 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.3M | $13.2M | ||
| Q3 25 | $24.4M | $11.6M | ||
| Q2 25 | $24.2M | $11.2M | ||
| Q1 25 | $24.1M | $9.2M | ||
| Q4 24 | $24.0M | $8.3M | ||
| Q3 24 | $24.4M | $7.3M | ||
| Q2 24 | $23.9M | $7.4M | ||
| Q1 24 | $23.4M | $6.5M |
| Q4 25 | $-4.3M | $-9.8M | ||
| Q3 25 | $-2.7M | $-10.8M | ||
| Q2 25 | $-2.6M | $-8.3M | ||
| Q1 25 | $-2.4M | $-10.4M | ||
| Q4 24 | $-2.1M | $-10.1M | ||
| Q3 24 | $-2.2M | $-2.4M | ||
| Q2 24 | $-2.3M | $-4.3M | ||
| Q1 24 | $-3.2M | $-13.2M |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
| Q4 25 | -14.3% | -24.8% | ||
| Q3 25 | -13.7% | -77.9% | ||
| Q2 25 | -12.2% | -65.4% | ||
| Q1 25 | -11.3% | -79.9% | ||
| Q4 24 | -14.3% | -91.8% | ||
| Q3 24 | -11.7% | -118.9% | ||
| Q2 24 | -11.6% | -111.0% | ||
| Q1 24 | -14.0% | -180.8% |
| Q4 25 | -17.8% | -73.9% | ||
| Q3 25 | -11.1% | -93.5% | ||
| Q2 25 | -10.6% | -73.9% | ||
| Q1 25 | -9.8% | -113.2% | ||
| Q4 24 | -8.6% | -122.4% | ||
| Q3 24 | -9.0% | -32.6% | ||
| Q2 24 | -9.8% | -58.8% | ||
| Q1 24 | -13.5% | -204.5% |
| Q4 25 | $-0.23 | $-0.22 | ||
| Q3 25 | $-0.14 | $-0.96 | ||
| Q2 25 | $-0.14 | $-0.27 | ||
| Q1 25 | $-0.12 | $-0.39 | ||
| Q4 24 | $-0.10 | $-0.38 | ||
| Q3 24 | $-0.12 | $-0.12 | ||
| Q2 24 | $-0.13 | $-0.21 | ||
| Q1 24 | $-0.17 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $25.1M | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $177.2M | $-33.9M |
| Total Assets | $709.8M | $35.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $25.1M | $20.4M | ||
| Q3 25 | $21.1M | $22.7M | ||
| Q2 25 | $23.6M | $26.5M | ||
| Q1 25 | $24.4M | $13.0M | ||
| Q4 24 | $27.9M | $8.5M | ||
| Q3 24 | $45.8M | $11.3M | ||
| Q2 24 | $18.9M | $16.5M | ||
| Q1 24 | $21.3M | $4.0M |
| Q4 25 | $177.2M | $-33.9M | ||
| Q3 25 | $186.7M | $-26.7M | ||
| Q2 25 | $192.1M | $-19.4M | ||
| Q1 25 | $198.5M | $-34.4M | ||
| Q4 24 | $205.0M | $-25.9M | ||
| Q3 24 | $209.9M | $-20.4M | ||
| Q2 24 | $214.7M | $-25.3M | ||
| Q1 24 | $220.7M | $-36.0M |
| Q4 25 | $709.8M | $35.3M | ||
| Q3 25 | $714.2M | $36.5M | ||
| Q2 25 | $699.6M | $41.3M | ||
| Q1 25 | $703.9M | $28.6M | ||
| Q4 24 | $713.5M | $24.0M | ||
| Q3 24 | $717.7M | $27.5M | ||
| Q2 24 | $694.7M | $32.4M | ||
| Q1 24 | $699.5M | $17.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.1M | $-2.5M |
| Free Cash FlowOCF − Capex | — | $-2.5M |
| FCF MarginFCF / Revenue | — | -19.1% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.1M | $-2.5M | ||
| Q3 25 | $9.1M | $-3.7M | ||
| Q2 25 | $8.5M | $-7.3M | ||
| Q1 25 | $246.0K | $-4.5M | ||
| Q4 24 | $24.1M | $-5.7M | ||
| Q3 24 | $9.0M | $-10.8M | ||
| Q2 24 | $6.9M | $-13.4M | ||
| Q1 24 | $653.0K | $-10.9M |
| Q4 25 | — | $-2.5M | ||
| Q3 25 | — | $-3.9M | ||
| Q2 25 | — | $-7.4M | ||
| Q1 25 | — | $-5.3M | ||
| Q4 24 | — | $-5.8M | ||
| Q3 24 | — | $-11.0M | ||
| Q2 24 | — | $-13.5M | ||
| Q1 24 | — | $-10.9M |
| Q4 25 | — | -19.1% | ||
| Q3 25 | — | -33.9% | ||
| Q2 25 | — | -66.1% | ||
| Q1 25 | — | -57.3% | ||
| Q4 24 | — | -69.7% | ||
| Q3 24 | — | -149.9% | ||
| Q2 24 | — | -183.1% | ||
| Q1 24 | — | -169.3% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 1.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BRT
| Unconsolidated Joint Ventures | $13.2M | 54% |
| Other | $11.1M | 46% |
TLSI
Segment breakdown not available.
